Search by Drug Name or NDC
NDC 00536-1302-97 Anti Nausea 1.87; 1.87; 21.5 g/5mL; g/5mL; mg/5mL Details
Anti Nausea 1.87; 1.87; 21.5 g/5mL; g/5mL; mg/5mL
Anti Nausea is a ORAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by RUGBY LABORATORIES. The primary component is DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID.
Product Information
| NDC | 00536-1302 |
|---|---|
| Product ID | 0536-1302_1a1eca4b-fa2d-4216-8ab8-0682ee6316bf |
| Associated GPIs | 50309903602000 |
| GCN Sequence Number | 004698 |
| GCN Sequence Number Description | phosphorated carbo(dext-fruct) SOLUTION ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 73710 |
| HICL Sequence Number | 015060 |
| HICL Sequence Number Description | PHOSPHORATED CARBOHYDRATE (DEXTROSE AND FRUCTOSE) |
| Brand/Generic | Brand |
| Proprietary Name | Anti Nausea |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dextrose(glucose),Levulose(fructose),Phosphoric acid |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | ORAL |
| Active Ingredient Strength | 1.87; 1.87; 21.5 |
| Active Ingredient Units | g/5mL; g/5mL; mg/5mL |
| Substance Name | DEXTROSE, UNSPECIFIED FORM; FRUCTOSE; PHOSPHORIC ACID |
| Labeler Name | RUGBY LABORATORIES |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00536-1302-97 (00536130297)
| NDC Package Code | 0536-1302-97 |
|---|---|
| Billing NDC | 00536130297 |
| Package | 1 BOTTLE in 1 CARTON (0536-1302-97) / 118 mL in 1 BOTTLE |
| Marketing Start Date | 2020-09-09 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.02675 |
| Pricing Unit | ML |
| Effective Date | 2024-01-17 |
| NDC Description | ANTI-NAUSEA LIQUID |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis